Compare PRTH & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRTH | BWAY |
|---|---|---|
| Founded | 2005 | 2003 |
| Country | United States | Israel |
| Employees | 1019 | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 451.1M | 450.8M |
| IPO Year | N/A | N/A |
| Metric | PRTH | BWAY |
|---|---|---|
| Price | $5.00 | $15.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $8.33 | ★ $13.25 |
| AVG Volume (30 Days) | ★ 217.6K | 167.5K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.76 | $309.69 |
| Revenue Next Year | $6.79 | $26.21 |
| P/E Ratio | ★ $10.38 | $81.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.44 | $7.84 |
| 52 Week High | $8.89 | $26.63 |
| Indicator | PRTH | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 50.65 | 56.49 |
| Support Level | $4.51 | $14.56 |
| Resistance Level | $6.01 | $16.63 |
| Average True Range (ATR) | 0.19 | 0.75 |
| MACD | 0.04 | 0.56 |
| Stochastic Oscillator | 72.65 | 89.05 |
Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium business enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments, and Enterprise Payments. SMB Payments segment which generates the majority of revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging Priority's proprietary software platform, distributed through ISO; the B2B Payments segment provides AP automation solutions to corporations, software partners, & industry FIs: and Enterprise Payments segment provides embedded payment & treasury solutions to enterprise customers to modernize legacy platforms & accelerate software partners' strategies to monetize payments.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.